Urogen Pharma's market cap is currently $445.63M. The company's EPS TTM is $-3.143; its P/E ratio is ―; Urogen Pharma is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is $-0.72. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 82.71M	$ 64.36M	$ 48.04M	$ 11.80M	$ 18.00K
Gross Profit	$ 73.35M	$ 56.70M	$ 42.88M	$ 10.79M	$ 18.00K
Operating Income	$ -65.54M	$ -79.04M	$ -92.29M	$ -126.74M	$ -109.48M
EBITDA	$ -63.83M	$ -78.03M	$ -90.15M	$ -122.71M	$ -108.15M
Net Income	$ -102.24M	$ -109.16M	$ -110.82M	$ -128.48M	$ -100.53M
Balance Sheet
Cash & Short-Term Investments	$ 136.97M	$ 99.96M	$ 89.81M	$ 103.91M	$ 147.08M
Total Assets	$ 178.31M	$ 136.24M	$ 119.75M	$ 122.00M	$ 202.39M
Total Debt	$ 100.21M	$ 99.12M	$ 398.00K	$ 1.50M	$ 2.60M
Net Debt	$ 4.39M	$ 43.72M	$ -43.96M	$ -102.41M	$ -47.08M
Total Liabilities	$ 243.52M	$ 224.98M	$ 111.33M	$ 25.65M	$ 22.09M
Stockholders' Equity	$ -65.21M	$ -88.74M	$ 8.41M	$ 96.36M	$ 180.30M
Cash Flow
Free Cash Flow	$ -76.57M	$ -87.81M	$ -85.64M	$ -107.10M	$ -71.34M
Operating Cash Flow	$ -76.38M	$ -87.56M	$ -84.89M	$ -105.89M	$ -71.02M
Investing Cash Flow	$ -953.00K	$ 1.06M	$ 4.07M	$ 93.24M	$ -145.59M
Financing Cash Flow	$ 116.93M	$ 97.13M	$ 72.32M	$ 16.53M	$ 165.25M

Currency in USD

Urogen Pharma Earnings and Revenue History

Income Statement >

Urogen Pharma Debt to Assets

Balance Sheet >

Urogen Pharma Cash Flow

Cash Flow >

Urogen Pharma Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing